netrashetty
Netra Shetty
Aflac Incorporated (pronounced /ˈæflæk/) is the largest provider of supplemental insurance in the United States,[1] founded in 1955 and based in MidTown Columbus, Georgia. In the United States, Aflac underwrites a wide range of insurance policies, but is perhaps best known for its payroll deduction insurance coverage, which pay cash benefits when a policyholder has a covered accident or illness. In Japan, the company is the second largest insurer overall and the largest life insurer,[2] and is also well known for its supplemental medical policies. Aflac currently is the number one Supplemental Health provider in the U.S. followed closely by Allstate Workplace Division. Aflac employs many people in Columbus and its other locations. Aflac has one of the largest field forces with over 70,000 agents in the U.S. In 2009 Aflac acquired Continental American Insurance Company to expand its coverage beyond voluntary benefits alone.
The American Family Life Assurance Company (AFLAC) (NYSE: AFL) sells medical and life insurance in the United States and Japan. 73% of the company's revenue comes from its Japanese segment, while the remaining 27% comes from its American operations.[1] In both segments, AFLAC focuses on offering supplemental coverage to people who may already have insurance from their employer or their government. AFLAC also offers customizable cancer insurance packages and different 'rider' policies that can be attached to an individual's insurance policy as a supplement for more specified coverage.
The investment portfolio of an insurance company is as important as ever in light of the crisis at the largest life insurer by market share, American International Group (AIG). On concern about AFLAC's portfolio exposure, the company's stock fell more than 30% in mid January, 2009. This was partially in response to losses in AFLAC's investment portfolio.
Since almost three-quarters of AFLAC's revenue comes from Japan, the company's reported earnings in the US are subject to changes in the Yen/Dollar exchange rate. Increases in the Yen/Dollar exchange rate translate into higher reported earnings in the US. However, the management of AFLAC claim that they rarely actually exchange any of their own assets, meaning that changes in the exchange rate do not effect their real performance.[2]
AFLAC has made the Standard & Poors Dividend Aristocrat list for 2009, and was one of 52 companies. Members of this list are companies on the S&P 500 (.SPX-E) that have raised their dividend every year for at least 25 years in a row.[3]
Contents
1 Company Overview
1.1 Business Financials
1.2 Business Segments
1.2.1 AFLAC Japan (73% of 2009 revenue)[1]
1.2.2 AFLAC US (27% of 2009 revenue)[1]
2 Key Trends and Forces
2.1 Exchange Rates
2.2 Interest Rates
2.3 Medical Treatment and Technology
3 Competition
4 References
Company Overview
Business Financials
Since 2001, AFLAC has had steadily increasing revenues. In 2009, its total revenues were $18.3 billion, compared to 2008's revenues of $ 16.6 billion. While its net income has remained positive, it has not had the same consistent and steady growth that AFLAC's revenues have had. In 2009, AFLAC's net income was $1.5 billion, compared to its net income of $1.25 billion in 2008.
Business Segments
AFLAC operates two main divisions: AFLAC Japan and AFLAC US. This means that earnings are calculated with a currency translation adjustment from Japanese Yen to US Dollars. However, AFLAC notes that they rarely actually convert assets between Yen and Dollars, so any exchange rate fluctuations do not materially affect the operations of the company.[2]
AFLAC Japan (73% of 2009 revenue)[1]
AFLAC Japan provides insurance that supplements Japan's national health insurance coverage. Management claims that consumers are shifting from dependency on the national health care system to private insurance.
Medical Policies AFLAC Japan offers different custom health insurance packages through its EVER medical insurance products. The EVER products insure against hospitalization expenses. EVER includes products targeted to specific types of the population, such as EVER Paid Up, a policy charging higher premiums earlier in life to guarantee lower premiums or no premiums when they are older. AFLAC has also added different insurance packages to continually target different population segments.
Cancer Life AFLAC Japan also offers cancer life insurance plans. These insurance plans cover hospitalization, outpatient, and extensive care expenses associated with a diagnosis and treatment of cancer. AFLAC offers some programs, such as its Rider MAX insurance against sickness and accidents, to be attached to its cancer life insurance policies.
Ordinary Life AFLAC's ordinary Life Insurance policies offer similar flexibility to AFLAC's other products. Some of these options include attaching the policy as a rider to one of AFLAC's other products. In addition, the Ordinary Life insurance products can be converted into other types of coverage such as medical coverage.
Rider MAX AFLAC Japan's Rider MAX policies are supplemental coverage policies that are offered to individuals already under Life Insurance coverage from one of AFLAC's other insurance products.
AFLAC US (27% of 2009 revenue)[1]
AFLAC US provides insurance that supplements primary medical coverage already has from their job or other provider.
Accident/Disability Coverage AFLAC's Accident and Disability coverage insures the policy holder against accidents and injuries. It also insures against accidental deaths. AFLAC has made this policy customizable by offering additional insurance to the policy holders that insure against disabilities.
Cancer Expense Insurance AFLAC's Cancer Expense Insurance offers many coverage for many different stages of cancer diagnosis and treatment. Typically, a policy holder receives a benefit if diagnosed with cancer and indemnity to cover hospitalization and treatment expenses. AFLAC has also made this plan customizable by its new coverage called Maximum DifferenceSM, which offers coverage for cancer prevention expenses and tailors to individuals' different medical and financial needs.
Hospital Indemnity Products AFLAC's Hospital Indemnity Insurance provides a benefit to a policy holder who is hospitalized as a result of an accident of sickness.
Fixed-Benefit Dental Coverage AFLAC offers benefits to help cover the expense of dental check-ups, cleanings, and some dental procedures.
Key Trends and Forces
Exchange Rates
73% of AFLAC's revenue comes from Japan.[1] This means that all of AFLAC Japan's earnings are translated into dollars for financial reporting. An increase in the exchange rate increases AFLAC's reported revenues. The following chart shows the USD/JPY exchange rates.
Interest Rates
AFLAC's investment portfolio is subject to risk from fluctuations in Interest Rates. In particular, AFLAC's bonds decrease in value with an increase in interest rates. According to AFLAC, an increase in interest rates of 1% decreases the fair value of the company's debt holdings from $54.7 billion to $48.9 billion.[4]
Medical Treatment and Technology
The field of medicine changes fast. New technologies and treatment techniques are always being developed, and AFLAC address this by constantly updating its policies and tailoring them to new medical expenses. For example, AFLAC's many rider policies allow individuals with outstanding insurance policies to purchase additional insurance against costs associated with new treatments.
Competition
There are many insurance companies with which AFLAC competes in its different markets and insurance products. Three of the largest are:
American International Group (AIG) offers many different insurance products through its subsidiaries. It operates in many different countries and offers General Insurance, Life Insurance, and financial services. AFLAC mainly competes with AIG's Life Insurance products, because AIG offers many other lines of insurance and operates in regions where AFLAC does not operate.
MetLife (MET) is an insurance company operating in the US, Latin America, Asia, and Europe. MetLife offers life insurance, annuities, automobile and homeowners insurance, reinsurance, group insurance products, and some financial services. MetLife's life insurance competes directly with AFLAC's life insurance products.
Prudential Financial (PRU) is one of the top life insurance providers in the country. Prudential operates in the US, Latin America, and Asia. Both AFLAC US and AFLAC Japan compete with Prudential.
Competition AFLAC American International Group (AIG) MetLife (MET)
Revenue from Premiums (millions of US$) $12,973 $58,798[5] $27,895[6]
Premiums Ceded (millions of US$) $2,884 $11,731[7] $2,454[8]
Investment Income (millions of US$) $2,333 $28,619[9] -$738[6]
Combined Ratio 83.8% 90.3%[10] 86.3%[11]
Latest Full Context Quarter Ending Date
2010/09
EBIT Margin
16.9%
EBITDA Margin
16.9%
Pre-Tax Profit Margin
16.3%
Interest Coverage
25.9
Leverage Ratio
8.8
Asset Turnover
0.2
Revenue to Assets
0.2
ROE from Total Operations
19.4%
Return on Invested Capital
19.1%
Return on Assets
2.2%
Debt/Common Equity Ratio
0.01
Price/Book Ratio (Price/Equity)
2.45
Book Value per Share
$23.62
Total Debt/ Equity
0.01
Long-Term Debt to Total Capital
0.01
Cash Flow per Share
$4.58
Free Cash Flow per Share
$12.77
Tangible Book Value per Share
$23.62
Price/Cash Flow Ratio
12.6
Price/Free Cash Flow Ratio
4.5
Price/Tangible Book Ratio
2.45
Most recent data
5-Year Averages
Return on Equity
18.3%
Return on Assets
2.1%
Return on Invested Capital
14.4%
Pre-Tax Profit Margin
14.1%
Post-Tax Profit Margin
9.3%
Net Profit Margin (Total Operations)
9.6%
Debt/Equity Ratio
0.27
Total Debt/Equity Ratio
0.27
The American Family Life Assurance Company (AFLAC) (NYSE: AFL) sells medical and life insurance in the United States and Japan. 73% of the company's revenue comes from its Japanese segment, while the remaining 27% comes from its American operations.[1] In both segments, AFLAC focuses on offering supplemental coverage to people who may already have insurance from their employer or their government. AFLAC also offers customizable cancer insurance packages and different 'rider' policies that can be attached to an individual's insurance policy as a supplement for more specified coverage.
The investment portfolio of an insurance company is as important as ever in light of the crisis at the largest life insurer by market share, American International Group (AIG). On concern about AFLAC's portfolio exposure, the company's stock fell more than 30% in mid January, 2009. This was partially in response to losses in AFLAC's investment portfolio.
Since almost three-quarters of AFLAC's revenue comes from Japan, the company's reported earnings in the US are subject to changes in the Yen/Dollar exchange rate. Increases in the Yen/Dollar exchange rate translate into higher reported earnings in the US. However, the management of AFLAC claim that they rarely actually exchange any of their own assets, meaning that changes in the exchange rate do not effect their real performance.[2]
AFLAC has made the Standard & Poors Dividend Aristocrat list for 2009, and was one of 52 companies. Members of this list are companies on the S&P 500 (.SPX-E) that have raised their dividend every year for at least 25 years in a row.[3]
Contents
1 Company Overview
1.1 Business Financials
1.2 Business Segments
1.2.1 AFLAC Japan (73% of 2009 revenue)[1]
1.2.2 AFLAC US (27% of 2009 revenue)[1]
2 Key Trends and Forces
2.1 Exchange Rates
2.2 Interest Rates
2.3 Medical Treatment and Technology
3 Competition
4 References
Company Overview
Business Financials
Since 2001, AFLAC has had steadily increasing revenues. In 2009, its total revenues were $18.3 billion, compared to 2008's revenues of $ 16.6 billion. While its net income has remained positive, it has not had the same consistent and steady growth that AFLAC's revenues have had. In 2009, AFLAC's net income was $1.5 billion, compared to its net income of $1.25 billion in 2008.
Business Segments
AFLAC operates two main divisions: AFLAC Japan and AFLAC US. This means that earnings are calculated with a currency translation adjustment from Japanese Yen to US Dollars. However, AFLAC notes that they rarely actually convert assets between Yen and Dollars, so any exchange rate fluctuations do not materially affect the operations of the company.[2]
AFLAC Japan (73% of 2009 revenue)[1]
AFLAC Japan provides insurance that supplements Japan's national health insurance coverage. Management claims that consumers are shifting from dependency on the national health care system to private insurance.
Medical Policies AFLAC Japan offers different custom health insurance packages through its EVER medical insurance products. The EVER products insure against hospitalization expenses. EVER includes products targeted to specific types of the population, such as EVER Paid Up, a policy charging higher premiums earlier in life to guarantee lower premiums or no premiums when they are older. AFLAC has also added different insurance packages to continually target different population segments.
Cancer Life AFLAC Japan also offers cancer life insurance plans. These insurance plans cover hospitalization, outpatient, and extensive care expenses associated with a diagnosis and treatment of cancer. AFLAC offers some programs, such as its Rider MAX insurance against sickness and accidents, to be attached to its cancer life insurance policies.
Ordinary Life AFLAC's ordinary Life Insurance policies offer similar flexibility to AFLAC's other products. Some of these options include attaching the policy as a rider to one of AFLAC's other products. In addition, the Ordinary Life insurance products can be converted into other types of coverage such as medical coverage.
Rider MAX AFLAC Japan's Rider MAX policies are supplemental coverage policies that are offered to individuals already under Life Insurance coverage from one of AFLAC's other insurance products.
AFLAC US (27% of 2009 revenue)[1]
AFLAC US provides insurance that supplements primary medical coverage already has from their job or other provider.
Accident/Disability Coverage AFLAC's Accident and Disability coverage insures the policy holder against accidents and injuries. It also insures against accidental deaths. AFLAC has made this policy customizable by offering additional insurance to the policy holders that insure against disabilities.
Cancer Expense Insurance AFLAC's Cancer Expense Insurance offers many coverage for many different stages of cancer diagnosis and treatment. Typically, a policy holder receives a benefit if diagnosed with cancer and indemnity to cover hospitalization and treatment expenses. AFLAC has also made this plan customizable by its new coverage called Maximum DifferenceSM, which offers coverage for cancer prevention expenses and tailors to individuals' different medical and financial needs.
Hospital Indemnity Products AFLAC's Hospital Indemnity Insurance provides a benefit to a policy holder who is hospitalized as a result of an accident of sickness.
Fixed-Benefit Dental Coverage AFLAC offers benefits to help cover the expense of dental check-ups, cleanings, and some dental procedures.
Key Trends and Forces
Exchange Rates
73% of AFLAC's revenue comes from Japan.[1] This means that all of AFLAC Japan's earnings are translated into dollars for financial reporting. An increase in the exchange rate increases AFLAC's reported revenues. The following chart shows the USD/JPY exchange rates.
Interest Rates
AFLAC's investment portfolio is subject to risk from fluctuations in Interest Rates. In particular, AFLAC's bonds decrease in value with an increase in interest rates. According to AFLAC, an increase in interest rates of 1% decreases the fair value of the company's debt holdings from $54.7 billion to $48.9 billion.[4]
Medical Treatment and Technology
The field of medicine changes fast. New technologies and treatment techniques are always being developed, and AFLAC address this by constantly updating its policies and tailoring them to new medical expenses. For example, AFLAC's many rider policies allow individuals with outstanding insurance policies to purchase additional insurance against costs associated with new treatments.
Competition
There are many insurance companies with which AFLAC competes in its different markets and insurance products. Three of the largest are:
American International Group (AIG) offers many different insurance products through its subsidiaries. It operates in many different countries and offers General Insurance, Life Insurance, and financial services. AFLAC mainly competes with AIG's Life Insurance products, because AIG offers many other lines of insurance and operates in regions where AFLAC does not operate.
MetLife (MET) is an insurance company operating in the US, Latin America, Asia, and Europe. MetLife offers life insurance, annuities, automobile and homeowners insurance, reinsurance, group insurance products, and some financial services. MetLife's life insurance competes directly with AFLAC's life insurance products.
Prudential Financial (PRU) is one of the top life insurance providers in the country. Prudential operates in the US, Latin America, and Asia. Both AFLAC US and AFLAC Japan compete with Prudential.
Competition AFLAC American International Group (AIG) MetLife (MET)
Revenue from Premiums (millions of US$) $12,973 $58,798[5] $27,895[6]
Premiums Ceded (millions of US$) $2,884 $11,731[7] $2,454[8]
Investment Income (millions of US$) $2,333 $28,619[9] -$738[6]
Combined Ratio 83.8% 90.3%[10] 86.3%[11]
Latest Full Context Quarter Ending Date
2010/09
EBIT Margin
16.9%
EBITDA Margin
16.9%
Pre-Tax Profit Margin
16.3%
Interest Coverage
25.9
Leverage Ratio
8.8
Asset Turnover
0.2
Revenue to Assets
0.2
ROE from Total Operations
19.4%
Return on Invested Capital
19.1%
Return on Assets
2.2%
Debt/Common Equity Ratio
0.01
Price/Book Ratio (Price/Equity)
2.45
Book Value per Share
$23.62
Total Debt/ Equity
0.01
Long-Term Debt to Total Capital
0.01
Cash Flow per Share
$4.58
Free Cash Flow per Share
$12.77
Tangible Book Value per Share
$23.62
Price/Cash Flow Ratio
12.6
Price/Free Cash Flow Ratio
4.5
Price/Tangible Book Ratio
2.45
Most recent data
5-Year Averages
Return on Equity
18.3%
Return on Assets
2.1%
Return on Invested Capital
14.4%
Pre-Tax Profit Margin
14.1%
Post-Tax Profit Margin
9.3%
Net Profit Margin (Total Operations)
9.6%
Debt/Equity Ratio
0.27
Total Debt/Equity Ratio
0.27
Last edited: